HIF1A and metabolic dysfunction-associated steatotic liver disease: It is well-documented that the human liver of NAFLD is often accompanied by increased FA β-oxidation [28] and HIF-1α activation [43], especially in the early stage of NAFLD, hepatosteatosis [19, 20], but the precise mechanism by which HIF-1α is activated remains uncertain at normoxia.